¼¼°èÀÇ °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå º¸°í¼­(2025³â)
Coronary Stents Global Market Report 2025
»óǰÄÚµå : 1703237
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,371,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,209,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,048,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ 8.3%ÀÇ ¼ºÀå·ü·Î 165¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ ÁßÀÇ ¼ºÀåÀº ½ÉÇ÷°ü Áúȯ À¯º´·ü Áõ°¡, °í·ÉÈ­, ½ÉÇ÷°ü °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Á¤ºÎ Áö¿ø ÇÁ·Î±×·¥ ¹× ÀÚ±Ý Áö¿ø, »ýȰ½À°üº´ À¯º´·ü Áõ°¡ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ½ºÅÙÆ® ±â¼ú Çõ½Å, À̹Ì¡ ±â¼ú Çõ½Å, Àü·«Àû Á¦ÈÞ ¹× ÆÄÆ®³Ê½Ê, ½ºÅÙÆ® Àç·á Çõ½Å, µðÁöÅÐ Çコ¿ÍÀÇ ±â¼ú ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü Áúȯ(CVDs)ÀÇ À¯º´·ü Áõ°¡´Â °ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CVD¿¡´Â °ü»óµ¿¸Æ Áúȯ, ½ÉºÎÀü, ³úÁ¹Áß, °íÇ÷¾Ð µî ´Ù¾çÇÑ ½ÉÀå ¹× Ç÷°ü ÁúȯÀÌ Æ÷ÇԵ˴ϴÙ. ½ÉÇ÷°ü Áúȯ Áõ°¡´Â Àα¸ °í·ÉÈ­, ºñ¸¸, ´ç´¢º´, ÁÂ½Ä »ýȰ½À°ü, ½Ä½À°ü Àå¾Ö, ½ºÆ®·¹½º µî À§Çè¿äÀÎ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. °ü»óµ¿¸Æ ½ºÅÙÆ®´Â °ü»óµ¿¸ÆÀÇ ÇùÂøÀ̳ª ¸·Èù ºÎºÐÀ» ¿­¾î ½ÉÀåÀ¸·ÎÀÇ Ç÷·ù¸¦ °³¼±ÇÏ°í ½ÉÀ帶ºñ À§ÇèÀ» °¨¼Ò½Ã۱⠶§¹®¿¡ CVD Ä¡·á¿¡ ÀÖÀ¸¸ç, ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 8¿ù ¹Ì±¹½ÉÀ庴ÇÐȸ°¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é 2025-2060³â±îÁö ¹Ì±¹³» ½ÉÇ÷°ü À§Çè¿äÀÎÀÌ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ´ç´¢º´ÀÌ 39.3% Áõ°¡ÇÑ 5,500¸¸ ¸í, ÀÌ»óÁöÁúÇ÷ÁõÀÌ 27.6% Áõ°¡ÇÑ 1¾ï 2,600¸¸ ¸í, °íÇ÷¾ÐÀÌ 25.1% Áõ°¡ÇÑ 1¾ï 6,200¸¸ ¸í, ºñ¸¸ÀÌ 18.3% Áõ°¡ÇÑ 1¾ï 2,600¸¸ ¸íÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. °¡Àå µÎµå·¯Áø Áõ°¡´Â ³úÁ¹Áß(33.8% Áõ°¡ÇÑ 1,500¸¸ ¸í)°ú ½ÉºÎÀü(33.4% Áõ°¡ÇÑ 1,300¸¸ ¸í)À̸ç, ÇãÇ÷¼º ½ÉÀåÁúȯ°ú ½ÉÀ帶ºñµµ Å« Æø Áõ°¡¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ CVD À¯º´·ü Áõ°¡´Â °ü»óµ¿¸Æ ½ºÅÙÆ® ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

°ü»óµ¿¸Æ ½ºÅÙÆ® ½ÃÀå ¾÷üµéÀº ±âÁ¸ º£¾î¸ÞÅ» ½ºÅÙÆ® ´ëºñ Àç¼ö¼úÀÇ Çʿ伺À» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ¾à¹°¿ëÃâÇü ½ºÅÙÆ® µî ÷´Ü Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¾à¹°¿ëÃâ ½ºÅÙÆ®´Â µ¿¸ÆÀÌ ´Ù½Ã Á¼¾ÆÁö´Â °ÍÀ» ¹æÁöÇÏ´Â ¾à¹°À» Á¡ÁøÀûÀ¸·Î ¹æÃâÇÏ´Â ¾à¹°À» ÄÚÆÃÇÑ Æ¯¼ö ÀåºñÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 5¿ù ¹Ì±¹ ÇコÄÉ¾î ±â¾÷ ¾Öº¸Æ®(Abbott)´Â Àεµ¿¡¼­ XIENCE Sierra Everolimus ¿ëÃâ °ü»óµ¿¸Æ ½ºÅÙÆ® ½Ã½ºÅÛÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ½ºÅÙÆ®´Â °­È­µÈ µðÀÚÀÎ, »õ·Î¿î Àü´Þ ½Ã½ºÅÛ, º¹ÀâÇÑ ÄÉÀ̽º¿¡ ¸Â´Â °íÀ¯ÇÑ »çÀÌÁî ¿É¼ÇÀ» Ư¡À¸·Î ÇÕ´Ï´Ù. ´Ù¸¥ XIENCE ½ºÅÙÆ®¿Í ¸¶Âù°¡Áö·Î µ¿¸Æ ÀçÆó»ö À§ÇèÀ» °¨¼Ò½ÃŰ´Â Ư¼ö ÄÚÆÃÀÌ Àû¿ëµÇ¾î ÀÖÀ¸¸ç, 120,000¸í ÀÌ»óÀÇ È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ 120°³ ÀÌ»óÀÇ Àӻ󿬱¸¸¦ ÅëÇØ ÀÔÁõµÈ ³ôÀº ¾ÈÀü¼ºÀ» ÀÚ¶ûÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ¹× °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Coronary stents are small, expandable tubes used to open narrowed or blocked coronary arteries, which supply blood to the heart muscle. Typically constructed from metal mesh, these devices are inserted during a procedure known as percutaneous coronary intervention (PCI) or angioplasty. The stent is delivered via a balloon catheter and expanded at the blockage site to restore proper blood flow.

The main types of coronary stents include dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents integrate drug-eluting and bioresorbable technologies to offer both medication release and gradual absorption of the stent structure. Various technologies used in their manufacture include laser cutting, 3D printing, microfabrication, nanotechnology, and electropolishing. Materials used in stent production can include cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. Stents can be self-expandable or balloon-expandable and are utilized by hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

The coronary stents market research report is one of a series of new reports from The Business Research Company that provides coronary stents market statistics, including coronary stents industry global market size, regional shares, competitors with a coronary stents market share, detailed coronary stents market segments, market trends and opportunities, and any further data you may need to thrive in the coronary stents industry. This coronary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary stents market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $12.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growing preference for minimally invasive procedures, expansion of healthcare access in emerging markets, rising healthcare expenditure, increase in percutaneous coronary interventions, growing number of cardiologists.

The coronary stents market size is expected to see strong growth in the next few years. It will grow to $16.5 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing incidence of cardiovascular diseases, aging population, rising awareness about cardiovascular health, supportive government programs and funding, growing incidence of lifestyle diseases. Major trends in the forecast period include innovations in stent technology, innovations in imaging technologies, strategic collaborations and partnerships, innovations in stent materials, technological integration with digital health.

The growing prevalence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market. CVDs encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population, increased rates of risk factors such as obesity, diabetes, sedentary lifestyles, poor diet, and stress. Coronary stents are crucial in treating CVDs as they help open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For example, a report from the American College of Cardiology in August 2022 projected significant increases in cardiovascular risk factors in the U.S. from 2025 to 2060. It predicted a 39.3% increase in diabetes cases to 55 million, a 27.6% rise in dyslipidemia to 126 million, a 25.1% increase in hypertension to 162 million, and an 18.3% rise in obesity to 126 million. The most notable increases are expected in stroke (33.8% rise to 15 million) and heart failure (33.4% rise to 13 million), with ischemic heart disease and heart attacks also showing substantial growth. This rising prevalence of CVDs is driving the demand for coronary stents.

Companies in the coronary stent market are focusing on developing advanced products such as drug-eluting stents to minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents are specialized devices coated with medication that gradually releases drugs to prevent the re-narrowing of arteries. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features an enhanced design, a new delivery system, and unique size options tailored for complex cases. It maintains a specialized coating to reduce the risk of artery re-blockage, consistent with other XIENCE stents, and boasts a strong safety record supported by over 120 clinical trials involving more than 120,000 patients.

In October 2022, Cordis, a US-based developer of cardiovascular and endovascular devices, acquired MedAlliance for an undisclosed amount. This acquisition will enable Cordis to reach two million patients globally by 2027 with the SELUTION SLR (Sustained Limus Release) drug-eluting balloon. Cordis will also co-promote MedAlliance's SELUTION SLR drug-eluting balloon in existing markets. MedAlliance is a Switzerland-based manufacturer of coronary stents.

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Stents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for coronary stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coronary stents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Coronary Stents Market Characteristics

3. Coronary Stents Market Trends And Strategies

4. Coronary Stents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Coronary Stents Growth Analysis And Strategic Analysis Framework

6. Coronary Stents Market Segmentation

7. Coronary Stents Market Regional And Country Analysis

8. Asia-Pacific Coronary Stents Market

9. China Coronary Stents Market

10. India Coronary Stents Market

11. Japan Coronary Stents Market

12. Australia Coronary Stents Market

13. Indonesia Coronary Stents Market

14. South Korea Coronary Stents Market

15. Western Europe Coronary Stents Market

16. UK Coronary Stents Market

17. Germany Coronary Stents Market

18. France Coronary Stents Market

19. Italy Coronary Stents Market

20. Spain Coronary Stents Market

21. Eastern Europe Coronary Stents Market

22. Russia Coronary Stents Market

23. North America Coronary Stents Market

24. USA Coronary Stents Market

25. Canada Coronary Stents Market

26. South America Coronary Stents Market

27. Brazil Coronary Stents Market

28. Middle East Coronary Stents Market

29. Africa Coronary Stents Market

30. Coronary Stents Market Competitive Landscape And Company Profiles

31. Coronary Stents Market Other Major And Innovative Companies

32. Global Coronary Stents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coronary Stents Market

34. Recent Developments In The Coronary Stents Market

35. Coronary Stents Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â